Juan Carlos Martinez Camarillo, MD

Associate Professor of Clinical Ophthalmology

Image of Juan Carlos Martinez Camarillo, MD
Is this your profile? Click to edit

Overview

Juan Carlos Martinez Camarillo MD, is a retinal surgeon and researcher, that works at the interface of medicine and biomedical engineering, focusing on the development of novel ophthalmic therapeutics. He is an Associate Professor of Clinical Ophthalmology at USC Roski Eye Institute and Director of the Translational Research In Vivo Core Facility at USC Ginsburg Institute for Biomedical Therapeutics. His multidisciplinary translational research includes drug development of new therapies to improve and treat diabetic retinopathy, choroidal neovascularization as well as developing anti-inflammatory, pro-resolving, and regenerative therapeutics for age-related macular degeneration (AMD), retinitis pigmentosa and ocular trauma. Dr. Martinez is also a collaborator in clinical studies for ocular trauma and stem cell-based therapy for advanced stages of dry age-related macular degeneration.
Dr. Martinez Camarillo has numerous publications, book chapters, co-editor of three ophthalmology books covering a wide range of areas from refractive surgery to selected topics in ophthalmology, patents and several talks and presentations in national and international ophthalmology conferences. Before moving to California and joining USC Roski Eye Institute, Dr. Martinez Camarillo was an Associate Professor in both, retina and vitreous fellowship and ophthalmology residency programs at the National Rehabilitation Institute (Instituto Nacional de Rehabilitación) endorsed by the National Autonomous University (Universidad Nacional Autónoma de México) in Mexico City.

Awards

  • La Salle University: La Salle University Scholarship, 2016
  • Salzburg Weill Cornell Seminar in Ophthalmology: Excellent Case Presentation, 2015
  • V INR Residents Congress (Ophthalmology): First prize for Best Research Thesis, 2010
  • USC Keck School of Medicine: Dean’s Pilot Funding Program, 2022
  • USC Roski Eye Institute: President Award for Outstanding Faculty Teaching and Dedicated Service, 2022

Education and Training

  • USC Doheny Eye Institute, Los Angeles, CA — Fellowship — 2012 — Retina and Vitreous Research Fellowship
  • Universidad de Guadalajara, Guadalajara, Mexico — Fellowship — 2013 — Clinical and Surgical Retina Fellowship
  • Universidad Nacional Autonoma de Mexico, Mexico City — Residency — 2011 — Ophthalmology Residency

Publications

  • Utility of ChatGPT-4o in Creating Patient Handouts in Ophthalmology: A Comparison With American Academy of Ophthalmology Educational Materials. Transl Vis Sci Technol. 2026 Feb 02; 15(2):14.. View in PubMed
  • Value of Reduced Time to Repair for Combat Ocular Trauma. Ophthalmology. 2026 01; 133(1):110-118.. View in PubMed
  • Four cases of endogenous Klebsiella endophthalmitis in Los Angeles County: A case series. Taiwan J Ophthalmol. 2025 Apr-Jun; 15(2):313-318.. View in PubMed
  • Scaling up polarized RPE cell supernatant production on parylene membrane. Exp Eye Res. 2024 03; 240:109789.. View in PubMed
  • Polarized RPE Secretome Preserves Photoreceptors in Retinal Dystrophic RCS Rats. Cells. 2023 06 22; 12(13).. View in PubMed
  • Development of a Surgical Technique for Subretinal Implants in Rats. J Vis Exp. 2022 12 02.. View in PubMed
  • An Oral Polyphenol Formulation to Modulate the Ocular Surface Inflammatory Process and to Improve the Symptomatology Associated with Dry Eye Disease. Nutrients. 2022 Aug 07; 14(15).. View in PubMed
  • Development of Moderate Intensity Focused Ultrasound (MIFU) for Ocular Drug Delivery. BME Front. 2022; 2022:9840678.. View in PubMed
  • Survival of an HLA-mismatched, bioengineered RPE implant in dry age-related macular degeneration. Stem Cell Reports. 2022 03 08; 17(3):448-458.. View in PubMed
  • Blocking Ocular Sympathetic Activity Inhibits Choroidal Neovascularization. Front Neurosci. 2021; 15:780841.. View in PubMed